Medical News

RSS

Cavit Sciences and McCoy form an agreement to finalize their merger

Cavit management has been negotiating with Randall McCoy and Joe Connell principle owners of McCoy Enterprises LLC to merge our companies. Maggie Smyth, CEO of Cavit states, “We all feel very good about this fit so we have added a breakup clause to show our commitment to each other”.

2 Sep 2009

SynerMed's announces a 35 percent growth in membership since the beginning of the first quarter of 2009

SynerMed, Inc. today announced a 35 percent growth in membership since the beginning of the first quarter of 2009. Representing 550,000 beneficiaries through its clients, SynerMed is the largest Medicaid managed service organization (MSO) in the country.

2 Sep 2009

The CyberKnife Robotic Radiosurgery System deployed at the CHUM

In operation since recently at the Centre hospitalier de l'Université de Montréal (CHUM), the CyberKnife(R) Robotic Radiosurgery System, is revolutionizing the treatment of both cancerous and non-cancerous tumors anywhere in the body. Used in radiation oncology, the CyberKnife System is the latest word in radiosurgery technology. Designed to destroy tumours using radiation beams, it is the first system of its kind to treat tumors non-invasively to be installed in Canada.

2 Sep 2009

BioDelivery Sciences International to integrate its Newark operations with company’s headquarters in Raleigh

BioDelivery Sciences International, Inc. (Nasdaq: BDSI), today announced the consolidation of the company’s laboratory and other operations in Newark, New Jersey to the company’s headquarters in Raleigh, North Carolina. BDSI will vacate its Newark facility by September 30, 2009.

2 Sep 2009

Combination of LIVALO and itraconazole drugs shows no adverse reactions

...

2 Sep 2009

Dr. Samadi of the Mount Sinai Medical Center stresses on prostate cancer awareness

September signifies the start of fall, back to school and back to homework. September is also National Prostate Cancer Awareness Month. The awareness month was proclaimed by President Bush in 2003, and bolstered later that year by former New York mayor Rudy Giuliani, a prostate cancer survivor, who became the spokesman for the National Prostate Cancer Coalition.

2 Sep 2009

Wallet-sized cards offer athletes tips for detecting and monitoring concussions

In response to a rising number of concussions and recent research which shows young athletes with repeated brain injuries are at great risk for future neurological problems, the Illinois Athletic Trainers Association (IATA) and the Chicago Institute of Neurosurgery and Neuroresearch (CINN) are offering a wallet-sized card with tips for detecting and monitoring concussions. The complimentary card is an educational tool for parents, coaches and others who work with young athletes to help them identify signs of a concussion.

2 Sep 2009

Arrayit receives patent certification from China

Arrayit Corporation (OTCBB: ARYC), a proprietary life sciences technology leader, announces that on August 31st, 2009 the company received a patent certificate from the most populous country on the planet, the People's Republic of China. The patent covers Dr. Mark Schena's microarray methods of genotyping multiple patient samples, commonly referred to as Arrayit's "Variation Identification Platform™" (VIP) technology.

2 Sep 2009

Validus chooses Ranbaxy to market an authorized generic version of Rocaltrol in the US

Ranbaxy Pharmaceuticals Inc. (RPI), a wholly owned subsidiary of Ranbaxy Laboratories Limited (RLL), Gurgaon, India, announced an agreement with Validus Pharmaceuticals LLC (Validus) to market and distribute an authorized generic version of Rocaltrol(R) (calcitriol) in both softgel capsules and an oral liquid formulation. Overall market sales for calcitriol softgel capsules and oral liquid were $70 million (IMS - MAT: June 2009).

2 Sep 2009

Ferguson OTC Center of Excellence launched to address increase use of OTC drugs

Ferguson, the founding professional agency of CommonHealth, today announced the launch of the Ferguson OTC (over-the-counter) Center of Excellence, a new initiative designed to address the rapid increase of promotion and use of OTC drugs.

2 Sep 2009

Thunderhead announces the selection of Thunderhead NOW solutions by Allianz Worldwide Care

Thunderhead, recognized innovators in document automation and multi-channel communications solutions, today announced that Allianz Worldwide Care has selected the Thunderhead NOW platform to create, produce and manage its multi-channel client communications.

2 Sep 2009

BRNI announces agreement to advance research on brain and neurological disorders

The Blanchette Rockefeller Neurosciences Institute (BRNI) announced today an agreement with a group of neurological specialists (Brain Injury Group) to examine possible confluences of the Group's work with brain injuries, head trauma, and strokes and BRNI's research.

2 Sep 2009

Analytical Technologies division of MDS to be acquired by Danaher

Danaher Corporation (NYSE: DHR) today announced that it has signed a definitive agreement with MDS Inc. (TSX: MDS; NYSE: MDZ) to acquire the Analytical Technologies division of MDS, which includes a 50% ownership position in Applied Biosystems/MDS Sciex joint venture ("AB SCIEX"), a mass spectrometry business, and a 100% ownership position in the former Molecular Devices Corporation, a bioresearch and analytical instrumentation company.

From Danaher 2 Sep 2009

Danaher to acquire mass spectrometry business from Life Technologies Corporation

Life Technologies Corporation (NASDAQ:LIFE) today announced it has signed a definitive agreement to sell its ownership stake in its mass spectrometry business, operated as a joint venture, to Danaher Corporation (NYSE:DHR) for $450 million in cash. Danaher has also signed an agreement to acquire Life Technologies’ joint venture partner in the mass spectrometry business, MDS Analytical Technologies, a division of MDS Inc. (NYSE:MDZ). The transaction is expected to close in the fourth quarter of 2009.

From Danaher 2 Sep 2009

First Edition: September 2, 2009

Baucus-Grassley Bipartisan Partnership Frays Under Health Reform Pressures For nearly a decade, the cross-aisle team of Democrat Max Baucus and Republican Charles Grassley has shaped dozens of tax cuts, trade measures and health bills on the Senate Finance Committee. That led many to predict that the partnership would be strong enough to broker bipartisan health care legislation this year (Kaiser Health News).

2 Sep 2009

FDA approves Astepro nasal spray 0.15% for the treatment of the symptoms of seasonal allergies

The U.S. Food and Drug Administration (FDA) has approved Astepro (azelastine) nasal spray 0.15% for the treatment of the symptoms of seasonal and perennial allergic rhinitis.

2 Sep 2009

Hope for limiting skin toxicity of cancer drug users

There may be a way around the harsh skin toxicity associated with a widely used cancer drug, according to a study published online this week in Cancer Biology and Therapy by researchers from City of Hope and the Kimmel Cancer at Jefferson.

2 Sep 2009

Irregular heartbeat is a common cause of stroke

Mellanie True Hills knows personally the toll that atrial fibrillation (afib) takes. Just two years ago, with a sense of urgency about afib that only a survivor can possess, she designated September as Atrial Fibrillation Month.

2 Sep 2009

Department of Health Care Services 2009 Gold Quality Award for SFHP

San Francisco Health Plan (SFHP), the City's community public health plan, today announced that it has received the Department of Health Care Services 2009 Gold Quality Award, ranking the plan as a leader in quality care throughout the state of California for Medi-Cal managed care plans.

2 Sep 2009

Ektron reports growth as more consumers select Ektron CMS400.NET

Ektron Inc., a technology and market leader in Web content management software, reports a steady growth in customers in the Healthcare industry. Ektron attributes this growth to its Healthcare Practice, a team dedicated to working with healthcare providers in the development of their Web strategy using Ektron CMS400.NET.

2 Sep 2009

Medical News

Cavit Sciences and McCoy form an agreement to finalize their merger

SynerMed's announces a 35 percent growth in membership since the beginning of the first quarter of 2009

The CyberKnife Robotic Radiosurgery System deployed at the CHUM

BioDelivery Sciences International to integrate its Newark operations with company’s headquarters in Raleigh

Combination of LIVALO and itraconazole drugs shows no adverse reactions

Dr. Samadi of the Mount Sinai Medical Center stresses on prostate cancer awareness

Wallet-sized cards offer athletes tips for detecting and monitoring concussions

Arrayit receives patent certification from China

Validus chooses Ranbaxy to market an authorized generic version of Rocaltrol in the US

Ferguson OTC Center of Excellence launched to address increase use of OTC drugs

Thunderhead announces the selection of Thunderhead NOW solutions by Allianz Worldwide Care

BRNI announces agreement to advance research on brain and neurological disorders

Analytical Technologies division of MDS to be acquired by Danaher

Danaher to acquire mass spectrometry business from Life Technologies Corporation

First Edition: September 2, 2009

FDA approves Astepro nasal spray 0.15% for the treatment of the symptoms of seasonal allergies

Hope for limiting skin toxicity of cancer drug users

Irregular heartbeat is a common cause of stroke

Department of Health Care Services 2009 Gold Quality Award for SFHP

Ektron reports growth as more consumers select Ektron CMS400.NET

How can microdialysis benefit drug development

Global and Local Efforts to Take Action Against Hepatitis

Addressing Important Cardiac Biology Questions with Shotgun Top-Down Proteomics

Latest News